Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Mouse CD8a PE | Login | Anti-Mouse CD8a PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD19 APC | Login | Anti-Mouse CD19 APC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD19 Purified | Login | Anti-Mouse CD19 Purified | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a FITC | Login | Anti-Human CD8a FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a PE | Login | Anti-Human CD8a PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a Purified | Login | Anti-Human CD8a Purified | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a FITC | Login | Anti-Human CD8a FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8b PE | Login | Anti-Mouse CD8b PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD38 PE | Login | Anti-Human CD38 PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD140a (PDGF Receptor a) Biotin | Login | Anti-Mouse CD140a (PDGF Receptor a) Biotin | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a Purified | Login | Anti-Human CD8a Purified | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD86 (B7-2) PE | Login | Anti-Human CD86 (B7-2) PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8a PE | Login | Anti-Mouse CD8a PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD18 SAFIRE Purified | Login | Anti-Mouse CD18 SAFIRE Purified | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD38 APC | Login | Anti-Human CD38 APC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD19 BG Violet 450 | Login | Anti-Mouse CD19 BG Violet 450 | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD27 BG Violet 450 | Login | Anti-Human CD27 BG Violet 450 | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a PE | Login | Anti-Human CD8a PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD48 SAFIRE Purified | Login | Anti-Human CD48 SAFIRE Purified | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD105 (Endoglin) PE | Login | Anti-Mouse CD105 (Endoglin) PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD27 APC | Login | Anti-Human CD27 APC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD27 APC-Cyanine7 | Login | Anti-Human CD27 APC-Cyanine7 | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD8a PE | Login | Anti-Human CD8a PE | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD27 PE-Cyanine7 | Login | Anti-Human CD27 PE-Cyanine7 | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD19 FITC | Login | Anti-Mouse CD19 FITC | ||||||||||||||||
|
||||||||||||||||||


